Specialty Pharmacy Market Landscape. Developed by:

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Specialty Pharmacy Market Landscape. Developed by:"

Transcription

1 Specialty Pharmacy Market Landscape Developed by: 2016

2 AGENDA TOPIC Specialty Pharmacy Overview Specialty Drug Trend Utilization Specialty Pharmacy Provider Profiles and Services Specialty Pharmacy Provider Process and Flow of Funds Impact of SPP on Value-Based Purchasing Current and Future Trends in SPP Appendix: Specialty Pharmacy Provider Profiles Glossary of Terms 2

3 LEARNING OBJECTIVES SPECIALTY PHARMACY The Specialty Pharmacy Plan Primer will provide deep insights into the following areas: Understand the role specialty pharmacies play in the delivery of healthcare Identify and understand the largest providers of specialty pharmacy services Gain insights into how market consolidation is impacting specialty pharmacy Describe the different types of specialty pharmacies and key attributes of the largest providers Understand how value-based healthcare is impacting specialty pharmacies 3

4 WHAT IS SPECIALTY PHARMACY? Specialty pharmacy (SPP) focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in SPP range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions. SPPs provide most services to payers at no additional cost, while services provided to manufacturers are more often provided at an additional cost or fee-for-service basis. Core services provided to health plans most often include patient education materials, PA adjudication, medication adherence, and data reporting. Source: IMS Health Core services provided to manufacturers most often include REMs program administration. Source: HIRC,

5 GROWTH OF SPECIALTY DRUG COSTS U.S. sales of specialty drugs totaled approximately $124 billion in 2014 and accounted for one third of the total U.S. pharmaceutical market. Between 2009 and 2014, sales of specialty drugs increased 58%, and are projected to increase another 67% by Specialty drugs are expected to account for 50% of the total U.S. spend within the next five years. BILLIONS ($) $300 Prescription Drug Spend $410 $374 33% 50% 26% 15% 27% 21% The average annual retail cost for a specialty medication to treat a chronic condition was almost $29,000 in 2009, with some drugs costing as much as $750, % 40% 29% * Brands Generic Specialty Projected Source: HIRC s Managed Markets and National Accounts Service, 2015 Specialty Pharmacy Times,

6 EVOLVING COMPETITIVE STRUCTURE OF THE PBM MARKET Three PBMs controlled about 66 percent of the PBM market in It s likely that three PBMs will control about 69 percent of the PBM market year end 2016, but they will not be the same three as in Medimpact, 5% Humana 6% All Others*, 7% PBM MARKET SHARE BY TOTAL ADJUSTED PRESCRIPTIONS 2014 Total adjusted prescriptions include claims at a PBM s network pharmacies, equivalent prescriptions and specialty claims filled by a PBM s mail pharmacy. Source: Deuche Bank Securities, Inc. Express Scripts 29% Medimpact, 5% Prime, 6% All Others*, 7% Express Scripts 29% Prime 6% Catamaran 9% Current Market Structure CVS/Caremark 12% Future Market Structure OptumRx 13% CVS/Caremark 24% Humana + Aetna Lives from Caremark 18% OptumRx + Catamaran 22% NOTABLE MARKET ACTIVITY OptumRx acquired Catamaran in 2014 and completed the merger in July The new OptumRx is expected to serve about 65 million lives and fulfill about one billion prescriptions in Aetna acquired Humana in 2015 and will likely completed the merger in mid Aetna leadership is expected to not renew its contract with Caremark and shift/carve-in its lives to Humana Pharmacy Solutions. Walgreens acquired Rite Aid in 2015 and will likely complete the merger in mid It will then control Rite Aid s wholly owned PBM subsidiary EnvisionRx, which will have access to over 13,000 pharmacies. 6

7 VALUE-BASED PURCHASING HAS A DIRECT IMPACT ON SPP Quality initiatives impact the delivery and reimbursement of providers. CMMI PCORI IPAB ICER Medicare Star NCQA/HEDIS QRS (Healthcare Exchanges) New Entities Increased Quality Measure Development Quality Delivery System Payment Reform Value-Based Purchasing Initiatives ACOs PCMH Bundled Payments Hospital Readmission Penalties Pay-for- Performance Bundled Payments 7

8 TRENDS IN SPP Expanding Patient Population Technology Expands Patient Centric Care Biosimilar Growth Health Care Reform will continue to bring new patients to the market Increasing access to healthcare for newly insured patients will increase the demand for specialty treatments Out of pocket costs may impact how much demand is realized There will be increased use of technology and data within SPP With text messaged reminders, digital sensors, and other types of improved data tracking, SPPs are leveraging technological advances to improve the patient experience Virtual healthcare offers other opportunities to expand patient education and support Data analysis can help prescribers, pharmacists, and manufacturers understand detailed dynamics of patient access and utilization SP has a uniquely strong prior record of direct interaction with physicians and patients Providers are looking for ways to improve interaction between caregivers to create a total care ecosystem that fits each patient s needs Fragmented solutions negatively impact the patient experience, so the market will be looking for unifying platforms to maximize the patient experience while providing aggregate data to measure the patient journey Expansion of biosimilars will require expanded patient education efforts. Branded biologic oncology products alone currently represent more than $20 billion in global spending and are anticipated to be the top target for biosimilar development over the next 5 years 2015 saw the first biosimilar, Zarxio, enter the US market at a 15 percent discount. With at least four more pending FDA review and dozens more somewhere in the review process, biosimilars are on the rise in

Specialty Pharmacy Definition

Specialty Pharmacy Definition Isn t All of Special? Developing Services Presented to: 2015 ICHP Annual Meeting Presented on: September 10, 2015 Presented by: Lana Gerzenshtein, Pharm.D., BCPS The speaker has no conflicts of interest

More information

5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned

5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We

More information

Specialty Pharmacy? Disclosure. Objectives Technician

Specialty Pharmacy? Disclosure. Objectives Technician Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University

More information

Overview of the Specialty Drug Trend

Overview of the Specialty Drug Trend WHITE PAPER Overview of the Specialty Drug Trend Succeeding In The Rapidly Changing U.S. Specialty Market 1 Specialty drugs are prescribed to treat complex conditions such as cancer, HIV and inflammatory

More information

February 2014 Patient Savings Program Use Analysis

February 2014 Patient Savings Program Use Analysis Providing key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. February 2014

More information

RMIP Prescription Plan FAQ's

RMIP Prescription Plan FAQ's RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on

More information

Retail Pharmacy Trends. Ed Escalante, VP/GM Edgar Cardona, VPS May 13, 2013 San Francisco, CA

Retail Pharmacy Trends. Ed Escalante, VP/GM Edgar Cardona, VPS May 13, 2013 San Francisco, CA Retail Pharmacy Trends Ed Escalante, VP/GM Edgar Cardona, VPS May 13, 2013 San Francisco, CA About this presentation Knowing Your Market Helps You Plan Ahead Understanding the latest retail pharmacy trends

More information

Pharmacy Benefit Managers: What we do

Pharmacy Benefit Managers: What we do Pharmacy Benefit Managers: What we do Steve Boekenoogen, Pharm.D. Poulsbo, WA & San Diego CA Manager, Clinical Services & Integration MedImpact Healthcare Systems, Inc Dan Danielson, M.S., RPh. Lynnwood,

More information

Specialty Pharmacy. Oncology

Specialty Pharmacy. Oncology Specialty Pharmacy Oncology Background What are specialty drugs? Not an FDA designation No standard industry definition Categorized as: High cost (>$1,200 / month) Require special handling and administration

More information

The Rising Tide of Pharmacy Benefit Cost and Complexity: A health plans roadmap to optimizing pharmacy services relationships

The Rising Tide of Pharmacy Benefit Cost and Complexity: A health plans roadmap to optimizing pharmacy services relationships The Rising Tide of Pharmacy Benefit Cost and Complexity: A health plans roadmap to optimizing pharmacy services relationships New pharmacy benefit challenges After several years of manageable pharmacy

More information

Electronic Prior Authorization (epa)

Electronic Prior Authorization (epa) Electronic Prior Authorization (epa) This report summarizes the current state of the electronic prior authorization (epa) industry. The intent is to quantify current epa adoption rates, highlight implementation

More information

The Basics of Pharmacy Benefits Management (PBM) 2009

The Basics of Pharmacy Benefits Management (PBM) 2009 The Basics of Pharmacy Benefits Management (PBM) 2009 Andrew Kingery Pharmacy Account Management Virginia CE Forum 2009 Course# 201719 Objectives & Introduction Provide basic components of a PBM Define

More information

Specialty Drug Care: Case management services in Quebec

Specialty Drug Care: Case management services in Quebec Specialty Drug Care: Case management services in Quebec QUEBEC SUPPORTING HEALTHIER OUTCOMES Your health benefit plan is designed to provide you and your family with financial protection for a variety

More information

e -Prescribing An Information Brief

e -Prescribing An Information Brief e -Prescribing An Information Brief Prepared by: Maryland Health Care Commission June 2008 Introduction Technology creates efficiencies and opportunities in almost every industry, and health care is no

More information

FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM

FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM ABBVIE EMPLOYEES WANT TO KNOW What s New in 2015? AbbVie is making changes in its pharmacy benefit program to ensure our medical

More information

The Evolving Landscape of Payment Care Delivery and Manufacturer Implications of Coverage Expansion

The Evolving Landscape of Payment Care Delivery and Manufacturer Implications of Coverage Expansion November 2013 Edition Vol. 7, Issue 10 The Evolving Landscape of Payment Care Delivery and Manufacturer Implications of Coverage Expansion By Gordon Gochenauer, Director, Oncology Commercial Strategies,

More information

SUPPLEMENT. 2016 Benefits Enrollment. 2015 Key Dates. FOR PRE-MEDICARE RETIREES November 2015. November 2 Retiree Open Enrollment Begins

SUPPLEMENT. 2016 Benefits Enrollment. 2015 Key Dates. FOR PRE-MEDICARE RETIREES November 2015. November 2 Retiree Open Enrollment Begins 2016 Benefits Enrollment SUPPLEMENT Human Resources Finance & Administration FOR PRE-MEDICARE RETIREES November 2015 This newsletter supplement concerns current pre-medicare-eligible retirees and spouses.

More information

The Pharma/Payer Relationship Strategies for the Next Two Years

The Pharma/Payer Relationship Strategies for the Next Two Years Health & Life Sciences The Pharma/Payer Relationship Strategies for the Next Two Years by Mark Mozeson Nipon Das, M.D. The power to determine what pharmaceutical products are bought and at what price has

More information

The Excelsior Solutions Difference

The Excelsior Solutions Difference The Excelsior Solutions Difference Expert pharmacy benefit management (PBM) consulting team In-house pharmacists, PBM and Medicare Part D experts Former C-level PBM executives averaging 20+ years industry

More information

Drug Pricing, Repricing, Rebates, and Patient Access

Drug Pricing, Repricing, Rebates, and Patient Access Drug Pricing, Repricing, Rebates, and Patient Access Jack Hoadley, Ph.D. Health Policy Institute, Georgetown University Bipartisan Policy Center April 13, 2016 1 Credits and Notes Some of my drug policy

More information

ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT

ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT Accountable Care Analytics: Developing a Trusted 360 Degree View of the Patient Introduction Recent federal regulations have

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Monday, October 12, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 3 Title: Activity Type: Speaker: How to Create

More information

THE GROWTH IN SPECIALTY DRUG SPENDING FROM 2013 TO 2014

THE GROWTH IN SPECIALTY DRUG SPENDING FROM 2013 TO 2014 THE GROWTH IN SPECIALTY DRUG SPENDING FROM 2013 TO 2014 This report was written by HealthCore, a wholly-owned and independently operated health outcomes subsidiary of Anthem, Inc. The Growth in Specialty

More information

Physician Discovery Services Provide a Full Range of Physician Practice Solutions

Physician Discovery Services Provide a Full Range of Physician Practice Solutions Physician Discovery Services OUR SOLUTION Truven Health Physician Discovery Services experts provide insights into a hospital or health system s physician enterprise. With experience in physician assessment,

More information

Natalie Pons, Senior Vice President, Assistant General Counsel, Health Care Services. CVS Caremark Corporation

Natalie Pons, Senior Vice President, Assistant General Counsel, Health Care Services. CVS Caremark Corporation Prepared Statement of Natalie Pons, Senior Vice President, Assistant General Counsel, Health Care Services CVS Caremark Corporation Before the Subcommittee on Regulatory Reform, Commercial and Antitrust

More information

Summary. UnitedHealth Center for Health Reform & Modernization 1

Summary. UnitedHealth Center for Health Reform & Modernization 1 UnitedHealth Center for Health Reform & Modernization THE GROWTH OF SPECIALTY PHARMACY Current trends and future opportunities Issue Brief April 2014 Summary Innovative specialty drugs are providing important

More information

Health Care System. Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer

Health Care System. Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer Creating a More Connected Health Care System Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer Agenda Our Role in the Changing Health Care System CVS/minuteclinic: Growth and

More information

University of Nebraska Prescription Drug Program 2014

University of Nebraska Prescription Drug Program 2014 University of Nebraska Prescription Drug Program 2014 The University of Nebraska s prescription benefit program is administered by CVS Caremark, a leading national provider of prescription drug benefit

More information

Automating Specialty Pharmacy

Automating Specialty Pharmacy Automating Specialty Pharmacy Agenda Specialty Trends/Drivers How are Specialty Medications Ordered Dispensed Paid for Current Specialty Flows What problems/challenges can be solved by HIT REMS epa 2 What

More information

Arthritis Foundation Position Statement on Biosimilar Substitution

Arthritis Foundation Position Statement on Biosimilar Substitution Arthritis Foundation Position Statement on Biosimilar Substitution The Affordable Care Act creates a regulatory pathway for the approval of a new generation of biologic medications called biosimilars.

More information

Adapting Pharmaceutical Reimbursement Policies to Manage Spending on High-Cost Drugs

Adapting Pharmaceutical Reimbursement Policies to Manage Spending on High-Cost Drugs Adapting Pharmaceutical Reimbursement Policies to Manage Spending on High-Cost Drugs Elizabeth Docteur, Principal, Elizabeth Docteur Consulting Ruth Lopert, Deputy Director, Pharmaceutical Policy & Strategy

More information

THE AFFORDABLE CARE ACT: KEY POINTS FOR PHARMACISTS. Sarah M. Smith, Pharm.D., BCACP Douglas H. Kay Symposium June 11, 2014

THE AFFORDABLE CARE ACT: KEY POINTS FOR PHARMACISTS. Sarah M. Smith, Pharm.D., BCACP Douglas H. Kay Symposium June 11, 2014 THE AFFORDABLE CARE ACT: KEY POINTS FOR PHARMACISTS Sarah M. Smith, Pharm.D., BCACP Douglas H. Kay Symposium June 11, 2014 Objectives 1. Summarize the major changes the Affordable Care Act (ACA) will have

More information

UnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions

UnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions UnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions Q1. What members are impacted by the UnitedHealthcare Injectable Chemotherapy PA Program? A. Beginning

More information

Below are some frequently asked questions that will provide you with valuable information.

Below are some frequently asked questions that will provide you with valuable information. Welcome to your prescription drug benefit administered by CVS Caremark. Your prescription benefit is designed to bring you quality pharmacy care that will help you save money. Below are some frequently

More information

Prescription Plan FAQ s

Prescription Plan FAQ s Prescription Plan FAQ s What is a specialty medication? Specialty medication is the term used to describe certain medications and a set of services designed to meet the particular needs of people who take

More information

Specialty Pharmacy in Community Pharmacy: The Time Is Now and How!

Specialty Pharmacy in Community Pharmacy: The Time Is Now and How! Specialty Pharmacy in Community Pharmacy: The Time Is Now and How! Dan Steiber, R.Ph., VCG & Associates Dean P. Erhardt, M.B.A., VCG & Associates Prepared on behalf of the NACDS Pharmacy Industry Council

More information

Specialty Pharmacy. Business Plan. July 8, 2013. 2013 RUSH University Medical Center

Specialty Pharmacy. Business Plan. July 8, 2013. 2013 RUSH University Medical Center Specialty Pharmacy Business Plan July 8, 2013 Specialty Pharmaceuticals What are they? Biotech/gene-based therapy Require special handling Newer products oral or self- administered One third have REMS

More information

WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain

WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing

More information

Key Medicare Issues for Coverage and Reimbursement of Specialty Pharmaceuticals

Key Medicare Issues for Coverage and Reimbursement of Specialty Pharmaceuticals Background Paper July 2008 Key Medicare Issues for Coverage and Reimbursement of Specialty Pharmaceuticals Advances in biotechnology have brought many effective new treatments for serious and debilitating

More information

HRI s closer look Healthcare s alternative payment landscape

HRI s closer look Healthcare s alternative payment landscape HRI s closer look Healthcare s alternative payment landscape CMS Payment Changes 2015-2018 Medicare s commitment towards quality-based payments grows. 80% 20% 85% 30% 90% 50% All Medicare payments Percentage

More information

UHC Branded Specialty Pharmacy Program

UHC Branded Specialty Pharmacy Program UHC Branded Specialty Pharmacy Program Evolution to Implementation Jake Groenewold, Senior Vice President, UHC Doug Smith, PharmD, Senior Director, UHC Kevin Colgan, MA, FASHP, Corporate Director of Pharmacy,

More information

Formulary Management

Formulary Management Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective

More information

The Facts, Figures and Trends in U.S. Pharmaceutical Distribution Gayle C. Johnston, President, CuraScript SD Miguel Rodriguez, Senior Product

The Facts, Figures and Trends in U.S. Pharmaceutical Distribution Gayle C. Johnston, President, CuraScript SD Miguel Rodriguez, Senior Product The Facts, Figures and Trends in U.S. Pharmaceutical Distribution Gayle C. Johnston, President, CuraScript SD Miguel Rodriguez, Senior Product Manager, CuraScript SD 2015 Distribution Management Conference

More information

Specialty Drug Hyperinflation:

Specialty Drug Hyperinflation: Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System Specialty drugs 1 offer important hope for many patients with complex, hard-to-treat illnesses. While the price of specialty

More information

Helping You Achieve Better Clinical and Financial Health

Helping You Achieve Better Clinical and Financial Health McKesson Business Performance Services Accountable Care Services Helping You Achieve Better Clinical and Financial Health 1 We recognized that fee-for-service would decrease and value-based care would

More information

Express Scripts Contribution to St. Louis and Missouri

Express Scripts Contribution to St. Louis and Missouri Express Scripts Contribution to St. Louis and Missouri Edward C. Lawrence, PhD Jane Qingjiang Qu, MBA, MA November 15, 2010 Executive Summary Express Scripts is providing significant economic benefits

More information

Princeton University Prescription Drug Plan Summary Plan Description

Princeton University Prescription Drug Plan Summary Plan Description Princeton University Prescription Drug Plan Summary Plan Description Princeton University Prescription Drug Plan Summary Plan Description January 2015 Contents Introduction... 1 How the Plan Works... 2

More information

Novel Opportunities for Engagement Utilizing in House Pharmacy Services

Novel Opportunities for Engagement Utilizing in House Pharmacy Services Novel Opportunities for Engagement Utilizing in House Pharmacy Services Ray Bailey, BSPharm RPh Director of Pharmacy, FCS Rx to Go Pharmacy rbailey@flcancer.com Angel Aslo, Pharm.D. Director of Pharmacy,

More information

Specialty Drugs: AN EVOLVING COMMERCIAL MODEL

Specialty Drugs: AN EVOLVING COMMERCIAL MODEL Published in February 2014 COVER STORY Copyright 2014 by PharmaLinx LLC Specialty Drugs: AN EVOLVING COMMERCIAL MODEL Robin Robinson A changing marketplace creates new challenges and new business models

More information

Health Care Environment

Health Care Environment Disclosures Anne L. Burns declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts,

More information

New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee

New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee PICA PRESCRIPTION DRUG PROGRAM Self-Injectable Medications Chemotherapy Medications Questions & Answers Last

More information

2016 PHARMACY. Benefit Summary Book. RXSUMBK2016 www.fepblue.org

2016 PHARMACY. Benefit Summary Book. RXSUMBK2016 www.fepblue.org 2016 Benefit Summary Book RXSUMBK2016 www.fepblue.org REVIEW THIS SUMMARY BOOKLET TO LEARN HOW TO GET THE MOST FROM YOUR PRESCRIPTION BENEFIT. THIS INCLUDES INFORMATION ABOUT: n Your prescription drug

More information

HEALTHCARE REFORM SOLUTIONS. Designing a Pharmacy Benefit for the New Public Health Exchange Consumers

HEALTHCARE REFORM SOLUTIONS. Designing a Pharmacy Benefit for the New Public Health Exchange Consumers HEALTHCARE REFORM SOLUTIONS Designing a Pharmacy Benefit for the New Public Health Exchange Consumers FEBRUARY 2013 EXECUTIVE SUMMARY Designing a Pharmacy Benefit for the New Public Health Insurance Exchange

More information

Population Health Management: Advancing Your Position in the Journey to Value-Based Care

Population Health Management: Advancing Your Position in the Journey to Value-Based Care Population Health Management: Advancing Your Position in the Journey to Value-Based Care Webcast Session One: An Integrated Approach to Population Health Management 11 August 2015 Welcome & Introductions

More information

Specialty drug program. Save time. Save money. Feel good.

Specialty drug program. Save time. Save money. Feel good. Specialty drug program Save time. Save money. Feel good. What are specialty drugs? Specialty drugs are used to treat serious or ongoing medical conditions such as multiple sclerosis, hemophilia, hepatitis

More information

Chapter 422. (House Bill 761) Health Insurance Specialty Drugs

Chapter 422. (House Bill 761) Health Insurance Specialty Drugs Chapter 422 (House Bill 761) AN ACT concerning Health Insurance Specialty Drugs FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from

More information

Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services

Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Building a Specialty Pharmacy Business Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Overview Agenda Brief overview of Fairview Barriers for hospital/health

More information

Health Insurance and Cancer Drug Reimbursement

Health Insurance and Cancer Drug Reimbursement Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Health Insurance and Cancer Drug Reimbursement Michael Kolodziej, M.D., FACP National Medical Director, Oncology

More information

Accountable Care Organizations and Patient-Centered Medical Homes

Accountable Care Organizations and Patient-Centered Medical Homes Emerging Topics in Healthcare Reform Accountable Care Organizations and Patient-Centered Medical Homes Janssen Pharmaceuticals, Inc. Accountable Care Organizations and Patient-Centered Medical Homes The

More information

PRESCRIPTION MEDICINES: COSTS IN CONTEXT

PRESCRIPTION MEDICINES: COSTS IN CONTEXT PRESCRIPTION MEDICINES: COSTS IN CONTEXT 2015 Since 2000, biopharmaceutical companies have brought MORE THAN 500 NEW TREATMENTS AND CURES to U.S. patients In the last 100 years, medicines have helped raise

More information

Best Practices and Strategies to Engage ACOs, Incentive Programs and Emerging Payment Models JUSTIN T. BARNES

Best Practices and Strategies to Engage ACOs, Incentive Programs and Emerging Payment Models JUSTIN T. BARNES Best Practices and Strategies to Engage ACOs, Incentive Programs and Emerging Payment Models JUSTIN T. BARNES CHAIRMAN EMERITUS, EHR ASSOCIATION CO-CHAIR, ACCOUNTABLE CARE COMMUNITY OF PRACTICE About Justin

More information

SPECIALTY TREND MANAGEMENT

SPECIALTY TREND MANAGEMENT SPECIALTY TREND MANAGEMENT Table of Contents Specialty drives pharmacy trend... Chapter 1 Managing price, mix and utilization... Chapter 2 Expand preferred drug strategies... Chapter 3 Cost-effective site

More information

October 18, 2013. Articulating the Value Proposition of Innovative Medical Technologies in the Healthcare Reform Landscape

October 18, 2013. Articulating the Value Proposition of Innovative Medical Technologies in the Healthcare Reform Landscape October 18, 2013 Articulating the Value Proposition of Innovative Medical Technologies in the Healthcare Reform Landscape Outline The Changing Landscape Evolving Care Delivery and Incentive Models Provider

More information

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia New England Healthcare Institute NEHI Innovation Series March 2004 Executive Summary From drugs and medical devices, to information

More information

Strategic Issues in Managing the Specialty Pharmacy Benefit. Tim Watson, PharmD, MBA

Strategic Issues in Managing the Specialty Pharmacy Benefit. Tim Watson, PharmD, MBA Strategic Issues in Managing the Specialty Pharmacy Benefit Tim Watson, PharmD, MBA Strategic Issues in Specialty Pharmacy Management Specialty pharmacy goals: Provide a reliable source for hard-to-find

More information

Population health management:

Population health management: GE Healthcare Population health management: Navigating successfully from volume to value In the new world of value-based care and risk-sharing compensation, success will depend on how well provider organizations

More information

Understanding your Blue Cross prescription drug plan

Understanding your Blue Cross prescription drug plan Understanding your Blue Cross prescription drug plan Blue Cross Blue Shield of Michigan gives you comprehensive coverage for your medications. Your prescription drug plan includes Blue Cross support and

More information

Here for you. Here for your health.

Here for you. Here for your health. Here for you. Here for your health. A guide to your plan Contact information This guide to your plan can help you make the most of your health care and Assurant Health s Customer Care Center can do the

More information

Northwest Georgia Oncology Centers, P.C.

Northwest Georgia Oncology Centers, P.C. Northwest Georgia Oncology Centers, P.C. High Deductibles and Out of Pocket HSA/HRA Plans (No up front collection) Medicare Advantage Plans Healthcare Exchange Plans Medicare only Cobra plans/high premiums

More information

Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach

Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove

More information

PBM Revenue Generation Secrets HEALTHCARE ANALYTICS

PBM Revenue Generation Secrets HEALTHCARE ANALYTICS PBM Revenue Generation Secrets HEALTHCARE ANALYTICS TODAY S AGENDA Brief background on the Prescription Benefits Manager (PBM) marketplace Basic Components of a PBM Contract How PBMs are exploiting contract

More information

Value-based care is about delivering the best outcomes at the lowest cost

Value-based care is about delivering the best outcomes at the lowest cost Hospital Solutions White Paper Series In cooperation with: October 2015 Hospital 100 Leadership & Strategy Conference October 19 to 21 Ritz-Carlton Key Biscayne, FL CLICK HERE TO LEARN MORE or visit the

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December

More information

OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING. September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV. For the Life Sciences Industry

OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING. September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV. For the Life Sciences Industry OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV For the Life Sciences Industry Register at DecisionResourcesGroup.com/Events DEAR COLLEAGUE, Cancer affects

More information

Leveraging Star Ratings in Medicare Within Community Pharmacies

Leveraging Star Ratings in Medicare Within Community Pharmacies Leveraging Star Ratings in Medicare Within Community Pharmacies ASAP Conference (Kiawah, SC) Friday, January 25, 2012 Laura Cranston, RPh Executive Director YOUR PQA LOGO Leveraging Star Ratings in Medicare

More information

Insight Into Evolving Payment and Delivery Models

Insight Into Evolving Payment and Delivery Models Insight Into Evolving Payment and Delivery Models Overview Objectives Provide an overview of Accountable Care Organization (ACO)-like payment and delivery models Demonstrate Genentech s commitment to patient

More information

HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy

HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy HMO Blue Texas SM, Blue Advantage HMO SM and Blue Premier SM Pharmacy In this Section are references unique to HMO Blue Texas, Blue Advantage HMO and Blue Premier. These network specific requirements will

More information

Realizing ACO Success with ICW Solutions

Realizing ACO Success with ICW Solutions Realizing ACO Success with ICW Solutions A Pathway to Collaborative Care Coordination and Care Management Decrease Healthcare Costs Improve Population Health Enhance Care for the Individual connect. manage.

More information

Prescription Drug Program Summary

Prescription Drug Program Summary Prescription Drug Program Summary Express Scripts is one of the most experienced full-service pharmacy benefit management firms (PBM) in the nation. Express Scripts contracts with pharmaceutical manufacturing

More information

The Impact of Medicare Part D on Pharmacy Benefit Managers

The Impact of Medicare Part D on Pharmacy Benefit Managers The Impact of Medicare Part D on Pharmacy Benefit Managers Actuaries Club of the Southwest and Southeastern Actuaries Conference Joint Annual Meeting November 17, 2006 Troy M. Filipek, FSA, MAAA Actuary

More information

Utilizing Clinical Integration to Align Physicians and Increase Market Share

Utilizing Clinical Integration to Align Physicians and Increase Market Share Utilizing Clinical Integration to Align Physicians and Increase Market Share Timothy J. Quinn, MD & Daniel J. Marino DISCLAIMER: The views and opinions expressed in this presentation are those of the author

More information

Pharmacist Market Trends

Pharmacist Market Trends t: 1.888.680.8088 Table of Contents Background.... 3 Pharmacist Landscape.... 4 Pharmacist Trends... 5 References.... 7 Defining the Survey Sample: Taking the Pulse Pharmacists 2012... 8 Key Findings:

More information

Finding More Value benefits magazine

Finding More Value benefits magazine As pharmacy benefits management continues to evolve, plan sponsors may be able to negotiate more favorable contracts and benefit their members by taking advantage of trends such as market consolidation

More information

Translating to the language of payers

Translating to the language of payers Translating to the language of payers Actuarial analyses of new drug therapies Gregory Warren, FSA, MAAA Vice President, Pharmacy Actuarial Consulting 303-714-1022 gregory.warren@optum.com 1 Why are actuaries

More information

Accountable Care Platform

Accountable Care Platform The shift toward increased collaboration, outcome-based payment and new benefit design is transforming how we pay for health care and how health care is delivered. UnitedHealthcare is taking an industry

More information

Overview of the BCBSRI Prescription Management Program

Overview of the BCBSRI Prescription Management Program Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed

More information

Session 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs. Laura Jenkins Jirele

Session 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs. Laura Jenkins Jirele Session 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs Laura Jenkins Jirele PMSA Virtual University PMSA Virtual University is conducting this four part webinar

More information

scriptsourcing THE NEXT 5 YEARS OF RX COSTS AND HOW THEY WILL IMPACT YOUR BOTTOM LINE ScriptSourcing Prescription Advocacy Services

scriptsourcing THE NEXT 5 YEARS OF RX COSTS AND HOW THEY WILL IMPACT YOUR BOTTOM LINE ScriptSourcing Prescription Advocacy Services scriptsourcing THE NEXT 5 YEARS OF RX COSTS AND HOW THEY WILL IMPACT YOUR BOTTOM LINE ScriptSourcing Prescription Advocacy Services Gary Becker, CEO Benefit Consultant, Risk Mitigation Expert, and Author

More information

Healthcare Brand Management

Healthcare Brand Management Healthcare Brand Management A Conversation About Accountable Care Business Models Healthcare Medical Pharmaceutical Directory.COM Healthcare Brand Management A Conversation About Accountable Care Business

More information

Understanding Specialty Pharmacy Management and Cost Control

Understanding Specialty Pharmacy Management and Cost Control Understanding Specialty Pharmacy Management and Cost Control JUNE 2010 Defining Concern 3 Why It Is Important To Focus On Specialty Pharmacy 3 Definition of Specialty Drugs and Specialty Pharmacy Management

More information

ACTIVELY MANAGED DRUG SOLUTIONS. for maintenance and specialty medication. Actively Managed Drug Solutions is not available in the province of Quebec

ACTIVELY MANAGED DRUG SOLUTIONS. for maintenance and specialty medication. Actively Managed Drug Solutions is not available in the province of Quebec ACTIVELY MANAGED DRUG SOLUTIONS for maintenance and specialty medication Actively Managed Drug Solutions is not available in the province of Quebec ARE YOU UNDERESTIMATING THE IMPACT OF CHRONIC DISEASE?

More information

Critical Access Hospitals and

Critical Access Hospitals and Critical Access Hospitals and Health Care Reform What s in it for you? Patient Protection and Affordable Care Act (ACA) Fundamental changes Moving Medicare from payment for services to payment for outcomes

More information

Specialty Drug Management Solutions You Haven t Heard Before

Specialty Drug Management Solutions You Haven t Heard Before Specialty Drug Management Solutions You Haven t Heard Before Sarah Martin, ASA, MAAA, CEBS Vice President, Senior Pharmacy Consultant Lockton Kansas City, Missouri The opinions expressed in this presentation

More information

Introduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.

Introduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors. Maintaining the Affordability of the Prescription Drug Benefit: How Managed Care Organizations Secure Price Concessions from Pharmaceutical Manufacturers Introduction The purpose of this paper is to explain

More information

ACA Care Delivery Reforms: Prospects for Progress. Jim Reschovsky, Ph.D. Senior Fellow Center for Studying Health System Change

ACA Care Delivery Reforms: Prospects for Progress. Jim Reschovsky, Ph.D. Senior Fellow Center for Studying Health System Change ACA Care Delivery Reforms: Prospects for Progress Jim Reschovsky, Ph.D. Senior Fellow Center for Studying Health System Change What are the problems? High health care costs Cost growth unsustainable Care

More information

DRIVING VALUE IN HEALTHCARE: PERSPECTIVES FROM TWO ACO EXECUTIVES, PART I

DRIVING VALUE IN HEALTHCARE: PERSPECTIVES FROM TWO ACO EXECUTIVES, PART I DRIVING VALUE IN HEALTHCARE: PERSPECTIVES FROM TWO ACO EXECUTIVES, PART I A firm understanding of the key components and drivers of healthcare reform is increasingly important within the pharmaceutical,

More information

T h e M A RY L A ND HEALTH CARE COMMISSION

T h e M A RY L A ND HEALTH CARE COMMISSION T h e MARYLAND HEALTH CARE COMMISSION Discussion Topics Overview Learning Objectives Electronic Health Records Health Information Exchange Telehealth 2 Overview - Maryland Health Care Commission Advancing

More information

FREE PRESCRIPTION DISCOUNT CARD AVAILABLE TO WELD COUNTY RESIDENTS

FREE PRESCRIPTION DISCOUNT CARD AVAILABLE TO WELD COUNTY RESIDENTS FREE PRESCRIPTION DISCOUNT CARD AVAILABLE TO WELD COUNTY RESIDENTS Money is tight for everyone these days. Many families work hard to stay within a budget, and, if they are lucky, they are also able to

More information

Impact of Health Reform on Prescription Drugs

Impact of Health Reform on Prescription Drugs Impact of Health Reform on Prescription Drugs 1 Indirect Effects Increased Rx Volume = More Prescriptions! Page 2 Retiree Drug Subsidy (RDS) Before HCR Tax-Free Subsidy RDS as taxdeductible income After

More information